Back to results
US 12,558,309 B2Granted
Method for morselizing and/or targeting pharmaceutically active principles to synovial tissue
AssigneeMedincell
InventorsGeorges Gaudriault, Sylvestre Grizot, Mark Hurtig, Matthew Shive
Life of this patent
Estimating the term…
Abstract
A method of targeting to the synovial tissue biodegradable drug delivery compositions or morselizing biodegradable drug delivery compositions are described. The biodegradable drug composition comprises a triblock copolymer containing a polyester and a polyethylene glycol and a diblock copolymer containing a polyester and an end-capped polyethylene glycol, as well as at least one pharmaceutically active principle is disclosed.
Claims3
A biodegradable drug delivery composition comprising:
- i) only a single biodegradable triblock copolymer and only a single biodegradable diblock copolymer, wherein
- (a) the single biodegradable triblock copolymer has the formula:
- PLAv-PEGw-PLAx
- wherein v and x are the number of repeat units ranging from 24 to 682 and w is the number of repeat units ranging from 4 to 273 and v=x or v≠x;
- and
- (b) the single biodegradable diblock copolymer has the formula:
- mPEGy-PLAz
- wherein y is the number of repeat units with y ranging from 3 to 45 and z ranging from 7 to 327, wherein the ratio of the biodegradable triblock copolymer of (a) and the biodegradable diblock copolymer of (b) is 3:2 to 1:19 in said biodegradable drug composition;
- and
- ii) at least one pharmaceutically active principle which is delivered through morselization of said biodegradable drug delivery composition,
- wherein said pharmaceutically active principle comprises a non-steroidal anti-inflammatory agent, and
- the PEG chain in at least one of the triblock and diblock copolymers is about 2 kDa.
9 more elements
A biodegradable drug delivery composition comprising:
- i) only a single biodegradable triblock copolymer and only a single biodegradable diblock copolymer, wherein
- (a) the single biodegradable triblock copolymer has the formula:
- PLAv-PEGw-PLAx
- wherein v and x are the number of repeat units ranging from 24 to 682 and w is the number of repeat units ranging from 4 to 273 and v=x or v≠x;
- and
- (b) the single biodegradable diblock copolymer has the formula:
- mPEGy-PLAz
- wherein y is the number of repeat units with y ranging from 3 to 45 and z ranging from 7 to 327, wherein the ratio of the biodegradable triblock copolymer of (a) and the biodegradable diblock copolymer of (b) is 3:2 to 1:19 in said biodegradable drug composition;
- and
- ii) at least one pharmaceutically active principle which is delivered through morselization of said biodegradable drug delivery composition,
- wherein said pharmaceutically active principle comprises celecoxib, and
- the PEG chain in at least one of the triblock and diblock copolymers is about 2 kDa.
9 more elements
Dependencies are inferred from the claim text.